Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
DanCann+pharma
-
search results
If you're not happy with the results, please do another search
GLP-1 and Keytruda steamed ahead in Q3
7 November, 2024
AdjuTec Pharma enters phase I with novel AMR treatment
1 November, 2024
EBD Group’s BIO-Europe event celebrates its 30th anniversary
1 November, 2024
Positive momentum for newly listed biotech companies
31 October, 2024
Robust data drives Alligator Bioscience forward
30 October, 2024
Alzinova’s new CEO: “The next six months will be really exciting”
10 October, 2024
BioStock met industry leaders at LSX
10 October, 2024
Sprint Bioscience CEO comments on deal potential
9 October, 2024
Lower up-front payments for startups
3 October, 2024
SynAct Pharma’s Chairman: ”We are confident we have the right strategy”
2 October, 2024
Investing in life science: From Seed to Success 2024
16 September, 2024
AdjuTec Pharma to start phase I trial with APC148
13 September, 2024
Spago Nanomedical strengthened management to reflect project progress
5 September, 2024
Curasight targets clinical proof-of-concept for uTREAT
29 August, 2024
Lipum recruits new CMO: “I have been following their research for...
26 August, 2024
Alzinova’s CEO: “We are a top actor in the Alzheimer’s field”
8 August, 2024
Danish pole position among best Nordic life science stocks in H1
8 July, 2024
Lipum strengthens the board with commercial expertise
5 July, 2024
Arcede Pharma heading towards liquidation
4 July, 2024
SynAct Pharma moves forward with filing process
4 July, 2024
“Unprecedented” phase II data for Alligator in pancreatic cancer
3 July, 2024
Spermosens: helping couples succeed in babymaking
2 July, 2024
Annexin comments on acquisition and focus on ANXV in ophthalmology
28 June, 2024
Aqilion and Merck sever ties
27 June, 2024
Curasight CEO comments on capital raise and milestone
25 June, 2024
BioStock Global Forum 2024
3 June, 2024
Ablivas CEO: “We remain on track for the interim analysis early...
29 May, 2024
AdjuTec advances toward phase I with regulatory green light
27 May, 2024
Full focus on financing and new CEO for Arcede
22 May, 2024
Flerie Invest continues to support Lipum
13 May, 2024
New results confirmation for Arcede Pharma
10 May, 2024
Spago’s CEO: Advancing the Tumorad programme comes first
7 May, 2024
SynAct Pharma’s CEO provides an update
2 May, 2024
Orion option exercise triggers milestone payment for Alligator
2 May, 2024
Oncoinvent strengthens board and cash position
24 April, 2024
Synact focuses on pushing forward rheumatoid arthritis project
2 April, 2024
Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”
27 March, 2024
WntResearch’s new CEO comments on his first month in the position
27 March, 2024
Synact’s new CEO: “I’m hitting the ground running”
22 March, 2024
Alligator’s CEO on current development and the rights issue
21 March, 2024
Chordate’s CEO presented at Swiss Nordic Bio
12 March, 2024
Saniona’s CEO: “Our development pipeline is stronger than ever”
5 March, 2024
Evaxion partners with MSD for vaccine development
28 February, 2024
Prolight Diagnostics CEO: “We deliver on all goals”
23 February, 2024
Adjutec applies for phase I start
22 February, 2024
U.S. biotechs raise more capital
20 February, 2024
Full speed ahead for Elicera in 2024
19 February, 2024
Curasight to accelerate therapeutic strategy by DKK 51.2 million capital raise
19 February, 2024
Deep dive into SynAct Pharma’s new strategy
8 February, 2024
Curasight gets first milestone payment from Curium
2 February, 2024
Oncoinvent’s CEO: “Radiopharmaceuticals has emerged as the hottest space in oncology”
31 January, 2024
Major shareholders in SynAct Pharma request board change
29 January, 2024
Saniona’s CEO: “financing will bring SAN711 towards proof of concept”
23 January, 2024
Targinta’s CEO: “Strong interest in ADCs in 2023”
22 January, 2024
Neola’s rapid development recognised at JPMorgan
17 January, 2024
New proposal potential game changer for Adjutec Pharma
11 January, 2024
2023’s strongest and weakest life science stocks
9 January, 2024
Alzinova’s CMO wants to bring forward a vaccine against Alzheimer’s
8 January, 2024
Arcede aims for clinic with TO1
8 January, 2024
Arcede Pharma appoints acting CEO
21 December, 2023
1
2
3
...
7
Page 1 of 7